Axsome Therapeutics, Inc. (AXSM)

Axsome Therapeutics Ratios and Metrics

Market cap in millions USD. Fiscal year is January - December.

Fiscal Year	Current	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019
Period Ending	Oct 29, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020	Dec 31, 2019
Market Capitalization	4,337	3,766	3,349	1,424	3,042	3,805
Market Cap Growth	22.11%	12.44%	135.22%	-53.20%	-20.03%	4425.27%
Enterprise Value	4,213	3,535	3,216	1,359	2,888	3,781
Last Close Price	90.35	79.59	77.13	37.78	81.47	103.36
PE Ratio	-	-15.10	-16.76	-10.89	-29.46	-51.45
PS Ratio	14.68	13.92	66.94	-	-	-
PB Ratio	41.99	19.72	30.57	91.10	26.74	21.29
P/FCF Ratio	-22.76	-25.86	-28.58	-13.12	-38.76	-82.01
P/OCF Ratio	-22.83	-25.96	-28.75	-13.16	-38.78	-82.04
EV/Sales Ratio	14.45	13.06	64.28	-	-	-
EV/EBITDA Ratio	-14.08	-19.38	-18.36	-10.91	-29.15	-56.37
EV/EBIT Ratio	-14.05	-19.33	-18.34	-10.90	-29.15	-56.34
EV/FCF Ratio	-21.91	-24.27	-27.44	-12.53	-36.79	-81.50
Debt / Equity Ratio	1.86	0.98	0.86	3.18	0.44	0.11
Debt / FCF Ratio	-1.14	-1.28	-0.81	-0.46	-0.64	-0.43
Asset Turnover	0.50	0.59	0.24	-	-	-
Inventory Turnover	2.31	2.68	-	-	-	-
Quick Ratio	2.34	3.46	2.47	3.75	7.85	8.98
Current Ratio	2.48	3.63	2.54	3.75	7.85	9.00
Return on Equity (ROE)	-161.69%	-159.21%	-298.97%	-201.51%	-70.36%	-76.08%
Return on Assets (ROA)	-28.23%	-24.86%	-52.29%	-56.91%	-30.46%	-35.55%
Return on Capital (ROIC)	-43.19%	-39.31%	-81.33%	-68.00%	-34.16%	-40.62%
Earnings Yield	-7.11%	-6.35%	-5.59%	-9.16%	-3.38%	-1.80%
FCF Yield	-3.87%	-3.87%	-3.50%	-7.62%	-2.58%	-1.22%
Buyback Yield / Dilution	-9.90%	-11.73%	-8.07%	-1.11%	-9.37%	-26.55%
Total Shareholder Return	-9.90%	-11.73%	-8.07%	-1.11%	-9.37%	-26.55%

Source: S&P Capital IQ. Standard template. Financial Sources.